Clinical AI needs more than fluent notes. It needs accuracy, provenance, human oversight, and real-world validation.
By Sonam Kumari
The next challenge for healthcare AI is not simply generating clinical notes. It is generating notes that clinicians can trust.
Generative AI and ambient AI scribes are increasingly being explored to reduce the administrative burden of clinical documentation. By converting clinician-patient conversations into structured notes, these systems could give clinicians more time to focus on patient care.
But a well-written note is not necessarily an accurate one.
An AI system can leave out a medication, change the meaning of a statement, confuse a past condition with a current one, or introduce information that was never discussed. In healthcare, these errors can affect patient safety, workflow, compliance, and accountability.
My analysis of 1,965 dialogue-note examples from MTS-Dialog, ACI-Bench, and PriMock57 illustrates why clinical AI needs to be evaluated beyond traditional language-generation measures. Factual accuracy, omissions, hallucinations, clinical concept retention, editing effort, evidence, and human review all matter.
Why Traditional AI Metrics Are Not Enough
Metrics such as ROUGE can measure how closely an AI-generated note resembles a reference note. However, similarity in wording does not necessarily mean that the clinical meaning is correct.
Consider a simple example. If a patient says, “I have no chest pain,” an AI system could generate, “Patient reports chest pain.” The sentence is fluent, but the clinical meaning has been reversed.
Similar errors can occur when a system omits a medication dosage, changes the certainty of a diagnosis, attributes a patient statement to the clinician, or leaves out follow-up instructions.
The benchmark results reinforce this concern. In the MTS-Dialog analysis, the strongest configuration achieved a ROUGE-1 score of 42.52 compared with 30.42 for the BART-large baseline. However, the same configuration had a factual F1 score of 0.7675, a 3% hallucination rate, and a 33% omission rate.
The implication is important: improving language quality does not automatically make clinical documentation safer.
Designing a More Reliable Workflow
A reliable clinical documentation system should be designed as an end-to-end workflow rather than simply connecting an audio recording to a large language model.
The process can be organized into five stages.
Capture and transcription. The system first converts the clinical conversation into text while preserving speaker identity, sequence, timestamps, and confidence information. Errors at this stage can affect everything that follows.
Clinical fact extraction. Before generating a narrative note, the system should identify information such as symptoms, diagnoses, medications, allergies, laboratory results, findings, temporal information, negations, and treatment plans. These facts should remain connected to the original conversation whenever possible.
Section-aware generation. The system can then generate different sections of the clinical note, including the history of present illness, objective findings, assessment, and plan. Each section has different accuracy requirements. For example, the history needs to preserve symptom chronology and important negative findings, while the plan needs to accurately capture medications, referrals, investigations, and follow-up instructions.
Evidence and provenance. Important statements should be traceable to the conversation that supports them. If the system generates information about a medication or treatment plan, clinicians should be able to identify its source.
Clinician verification. The generated note should remain a draft until it is reviewed and approved by an appropriately qualified clinician. The clinician should be able to identify missing information, correct errors, review supporting evidence, and approve the final record.
This approach positions AI as a documentation assistant rather than an autonomous author of the medical record.
Hallucinations Are Not the Only Problem
Healthcare AI discussions often focus on hallucinations, but omissions deserve similar attention.
In the analysis, one configuration achieved factual precision of 0.9408 with a hallucination rate of only 1%. However, its omission rate was 37%. Another configuration reduced omission to 33%, but its hallucination rate increased to 3%.
This illustrates an important trade-off. A system can avoid unsupported information while still producing an incomplete record. Conversely, a system that attempts to capture more information may increase the risk of introducing unsupported statements.
Clinical documentation therefore needs a balanced evaluation framework. Factual precision and recall should be considered alongside hallucination rates, critical omissions, and retention of clinically important concepts.
Human Review Should Be Part of the Product
Human oversight is sometimes viewed as a limitation of AI. For clinical documentation, it should instead be treated as a product requirement.
AI can help identify information that deserves additional attention, including medication names and dosages, allergies, diagnoses, abnormal findings, negations, follow-up instructions, and low-confidence transcription segments.
This can make review more targeted. Instead of asking clinicians to scrutinize every sentence equally, the system can direct attention toward information where an error could have greater consequences.
The goal is not to eliminate clinical accountability. It is to reduce administrative work while preserving the clinician’s responsibility for the final record.
What Healthcare Organizations Should Measure
Organizations evaluating clinical documentation AI should look beyond model benchmark scores.
Useful measures include documentation time saved per encounter, clinician editing time, acceptance rates, unsupported claims per note, critical errors, medication and allergy omissions, negation and temporal errors, clinician satisfaction, transcription failure rates, system availability, and model-version tracking.
These measures help answer a more important question: does the technology actually improve the clinical workflow?
A model can perform well on a benchmark while creating additional review work for clinicians. Deployment success is ultimately a workflow outcome, not simply a model benchmark outcome.
Privacy and Governance From the Start
Clinical conversations contain sensitive information, so privacy and governance should be considered from the beginning of product development.
Production systems should incorporate appropriate access controls, encryption, audit logging, retention policies, recording consent, model-version tracking, provenance, and controlled integration with electronic health records.
Testing should also reflect the diversity of real clinical environments. Accents, languages, speech conditions, and different patient populations can affect system performance. Results from a controlled English-language dataset may not predict how a system performs in practice.
Moving From Benchmarks to Real-World Validation
Benchmark datasets provide valuable information for comparing systems, but they cannot capture every condition found in clinical encounters.
Real consultations can involve interruptions, background noise, overlapping conversations, accents, incomplete histories, specialty-specific terminology, and rapidly changing clinical situations. The datasets used in this analysis also have limitations in size and representativeness.
Future evaluation should therefore include real clinical environments, multiple specialties, diverse patient populations, different languages, EHR integrations, clinician correction time, clinically significant errors, privacy considerations, and provenance accuracy.
Recent research is already examining how clinicians modify AI-generated drafts in real-world settings, reinforcing the importance of studying not only what AI generates but also what clinicians need to correct.¹
Five Questions for Healthcare AI Leaders
Healthcare organizations evaluating clinical documentation AI should consider five questions:
- Can the system show where important information came from?
- Does it measure omissions as well as hallucinations?
- Can clinicians review and correct the output efficiently?
- Are workflow and safety outcomes measured alongside model performance?
- Are privacy, governance, and auditability built into the product?
These questions shift the discussion from whether an AI model can generate a note to whether the complete system can be trusted in practice.
Conclusion
The next phase of clinical AI will not be defined simply by how well machines can write clinical notes. It will depend on whether those notes can be verified, corrected, monitored, and trusted.
Generative AI has significant potential to reduce the documentation burden on clinicians. However, healthcare requires more than fluent text. AI systems need to preserve clinical meaning, recognize uncertainty, provide evidence for important statements, and keep clinicians responsible for the final record.
The most valuable clinical AI may not be the system that tries to replace the clinician’s documentation process. It may be the one that handles repetitive work while making important information easier for clinicians to review.
The real opportunity is not simply generating more clinical notes. It is using AI to help create documentation that is accurate, explainable, and safe.
About the Author
Sonam Kumari is a technology and product professional with a background in computer science engineering, data analytics, healthcare technology, AI-enabled product development, and enterprise platforms. Her work focuses on applying artificial intelligence, data, and product strategy to complex healthcare and enterprise technology challenges.
